Raffles Medical Group Ltd (RAFLF)
USD 0.67
(0.0%)
USD 0.67
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 143.45 Million | 143.28 Million | 114.13 Million | 97.68 Million | 80.57 Million | 67.94 Million |
| Net Income | 68.31 Million | 106.94 Million | 62.37 Million | 49.85 Million | 44.82 Million | 52.13 Million |
| Depreciation & Amortization | 28.98 Million | 29.96 Million | 29.14 Million | 26.85 Million | 21.76 Million | 13.4 Million |
| Deferred income taxes | - | -91.74 Million | -50.38 Million | -52.91 Million | - | - |
| Stock-based compensation | 2.58 Million | 3.16 Million | 2.46 Million | 1.61 Million | 1.39 Million | - |
| Change in working capital | 72.73 Million | -24.48 Million | 10.5 Million | 5.82 Million | 13.97 Million | 3.74 Million |
| Other non-cash items | -29.15 Million | 119.44 Million | 60.02 Million | 66.44 Million | 34.1 Million | 23.72 Million |
| Investing Cash Flow | -9.4 Million | -18.73 Million | -39.14 Million | -48.01 Million | -73.23 Million | -77.87 Million |
| Investments in PPE | -15.55 Million | -18.85 Million | -39.13 Million | -45.44 Million | -73.16 Million | -23.04 Million |
| Acquisitions | 393.09 Thousand | 119.97 Thousand | 33.34 Thousand | 4539.78 | 2231.06 | -1.68 Million |
| Investment purchases | - | - | -48.17 Thousand | -2.6 Million | -78.08 Thousand | -53.15 Million |
| Sales/Maturities of investments | - | - | - | 31.77 Thousand | - | - |
| Other Investing Activities | 6.15 Million | 1.62 Million | -1.67 Million | -0.78 | -0.06 | -1.00 |
| Financing Cash Flow | -64.8 Million | -132.23 Million | -29.75 Million | -11.77 Million | 26.74 Million | 16.49 Million |
| Debt repayment | -8.68 Million | -70.35 Million | -5.15 Million | -11.43 Million | -45.9 Million | -27.4 Million |
| Dividends payments | -53.53 Million | -38.76 Million | -27.67 Million | -14.51 Million | -13.35 Million | -11.46 Million |
| Common Stock Repurchased | -4.31 Million | -18.14 Million | -2.39 Million | 0.99 | -297.47 Thousand | 54.8 Million |
| Common Stock Issuance | 5.63 Million | 4.49 Million | 4.14 Million | 588.65 Thousand | 730.3 Thousand | 565.66 Thousand |
| Other Financing Activities | 1.76 Million | -9.46 Million | 1.33 Million | 13.58 Million | -6.24 Million | 1.00 |
| Accounts receivables | 72.25 Million | -23.62 Million | -35.81 Million | -22.92 Million | -1.02 Million | 3.54 Million |
| Accounts payables | -28.28 Million | -5.22 Million | 45.29 Million | 28.62 Million | 11.14 Million | -2.26 Million |
| Inventory | 479.66 Thousand | 205.67 Thousand | 898.95 Thousand | -3.28 Million | -687.91 Thousand | 465.88 Thousand |
| Other working capital | 14.67 Million | 4.15 Million | 125.24 Thousand | 3.4 Million | 4.54 Million | 1.99 Million |
| Cash at beginning of period | 188.18 Million | 196.38 Million | 153.68 Million | 39.55 Million | 45.05 Million | 73.53 Million |
| Cash at end of period | 259.56 Million | 188.63 Million | 196.38 Million | 153.68 Million | 39.55 Million | 45.05 Million |
| Capital Expenditure | -15.55 Million | -18.85 Million | -39.13 Million | -45.44 Million | -73.16 Million | -23.04 Million |
| Effect of forex changes on cash | -675.17 Thousand | -1.54 Million | 811 Thousand | 1.22 Million | -1.05 Million | -35.04 Million |
| Net cash flow / Change in cash | 71.38 Million | -7.75 Million | 42.7 Million | 114.12 Million | -5.49 Million | -28.48 Million |
| Free Cash Flow | 127.9 Million | 124.43 Million | 75 Million | 52.24 Million | 7.4 Million | 44.9 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.29 Million | 11.35 Million | 11.47 Million | 68.27 Million | 11.08 Million | 22.12 Million |
| Depreciation & Amortization | 7.33 Million | 6.94 Million | 6.84 Million | 28.04 Million | 6.6 Million | 7.03 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 672.59 Thousand | 676.17 Thousand | 588.78 Thousand | 2.58 Million | 568.36 Thousand | 684.72 Thousand |
| Change in working capital | -8.4 Million | -8.45 Million | 14.21 Million | 67.34 Million | 13.72 Million | 255.47 Thousand |
| Other non-cash items | 1.84 Million | 2.28 Million | -9.4 Million | -13.05 Million | -9.08 Million | 16.73 Million |
| Investing Cash Flow | -2.43 Million | -2.44 Million | -2.61 Million | -16.22 Million | -2.52 Million | -2.03 Million |
| Investments in PPE | -4.3 Million | -4.32 Million | -4.18 Million | -16.61 Million | -4.04 Million | -3.5 Million |
| Acquisitions | -354.54 Thousand | - | 393.09 Thousand | 393.09 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.87 Million | 1.88 Million | 1.56 Million | 6.15 Million | 1.51 Million | 1.46 Million |
| Financing Cash Flow | -20.28 Million | -20.39 Million | -4.85 Million | -61.76 Million | -4.68 Million | -26.88 Million |
| Debt repayment | -545.45 Thousand | - | -112.09 Thousand | -59.83 Thousand | - | -50.99 Thousand |
| Dividends payments | -16.43 Million | -16.52 Million | - | -53.53 Million | - | -26.13 Million |
| Common Stock Repurchased | - | - | -2.15 Million | -4.31 Million | -2.08 Million | -0.20 |
| Common Stock Issuance | 185.01 Thousand | - | 905.85 Thousand | 5.63 Million | - | 4.61 Million |
| Other Financing Activities | -3.84 Million | -3.86 Million | -2.69 Million | -13.63 Thousand | -2.59 Million | -753.12 Thousand |
| Accounts receivables | -8.75 Million | -8.8 Million | 21.12 Million | 80.47 Million | 20.39 Million | 187.45 Thousand |
| Accounts payables | -4.58 Million | - | -24.77 Million | -28.28 Million | - | -3.41 Million |
| Inventory | 353.62 Thousand | 355.5 Thousand | 170.11 Thousand | 479.43 Thousand | 164.21 Thousand | 68.02 Thousand |
| Other working capital | 10.12 Million | - | -7.07 Million | 14.67 Million | -6.83 Million | 13.8 Million |
| Cash at beginning of period | 260.24 Million | - | 222.24 Million | 188.63 Million | 221.54 Million | 188.63 Million |
| Cash at end of period | 233.16 Million | -9.74 Million | 260.24 Million | 260.24 Million | 237.24 Million | 221.54 Million |
| Capital Expenditure | -4.3 Million | -4.32 Million | -4.18 Million | -16.61 Million | -4.04 Million | -3.5 Million |
| Effect of forex changes on cash | 282.82 Thousand | 284.33 Thousand | 8714.37 | -675.17 Thousand | 8412.09 | -337.92 Thousand |
| Net cash flow / Change in cash | -27.07 Million | -9.74 Million | 37.99 Million | 71.61 Million | 15.7 Million | 32.91 Million |
| Free Cash Flow | 8.43 Million | 8.48 Million | 19.53 Million | 130.58 Million | 18.86 Million | 43.33 Million |
PRRVF
IIJIY
QMCO
AGXKF
MSLVF
TMTNF